Caris Life Sciences, Inc. (CAI)
23.04
-0.92
(-3.84%)
USD |
NASDAQ |
Nov 13, 16:00
23.04
0.00 (0.00%)
After-Hours: 19:59
Caris Life Sciences Net Income (Quarterly) : 15.25M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 15.25M |
| June 30, 2026 | -0.637M |
| March 31, 2026 | -0.51M |
| December 31, 2025 | 81.96M |
| September 30, 2025 | 24.32M |
| June 30, 2025 | -71.79M |
| Date | Value |
|---|---|
| March 31, 2025 | -102.58M |
| December 31, 2024 | -36.95M |
| September 30, 2024 | -67.73M |
| June 30, 2024 | -66.19M |
| March 31, 2024 | -111.03M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Natera, Inc. | -59.91M |
| Myriad Genetics, Inc. | -43.90M |
| BioRestorative Therapies, Inc. | -2.154M |
| CareDx, Inc. | 19.29M |
| Exagen, Inc. | -6.336M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 275.36M |
| Total Expenses (Quarterly) | 260.11M |
| EPS Diluted (Quarterly) | 0.0517 |
| Enterprise Value | 6.302B |
| Gross Profit Margin (Quarterly) | 66.20% |
| Profit Margin (Quarterly) | 5.54% |
| Earnings Yield | 1.47% |
| Operating Earnings Yield | 2.13% |
| Normalized Earnings Yield | 1.758 |